What is he best known for?
The fields of study he is best known for:
- Immune system
- Gene
- T cell
His scientific interests lie mostly in Cytotoxic T cell, CD8, Immunology, T cell and Interleukin 21.
His Cytotoxic T cell research includes themes of Virology and Cell biology.
His CD8 research incorporates elements of Cancer research, Major histocompatibility complex and T-cell receptor.
The concepts of his T cell study are interwoven with issues in CTL* and Immune tolerance.
Hanspeter Pircher combines subjects such as Peripheral tolerance, Interleukin 12, Adoptive cell transfer and Antigen-presenting cell with his study of Interleukin 21.
His Antigen study incorporates themes from Molecular biology and Spleen.
His most cited work include:
- Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. (1076 citations)
- Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells (1006 citations)
- Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen (880 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cytotoxic T cell, Immunology, CD8, T cell and Molecular biology.
His studies in Cytotoxic T cell integrate themes in fields like Antigen and Virology.
His CD8 study combines topics in areas such as Cancer research and Major histocompatibility complex.
His research integrates issues of Genetically modified mouse, Priming, CTL* and Internal medicine in his study of T cell.
His work investigates the relationship between Molecular biology and topics such as T-cell receptor that intersect with problems in Transgene, Thymocyte, Gene rearrangement, Beta and Alpha chain.
The study incorporates disciplines such as Natural killer cell, Interleukin 12, Adoptive cell transfer and Cell biology in addition to Interleukin 21.
He most often published in these fields:
- Cytotoxic T cell (61.45%)
- Immunology (53.63%)
- CD8 (41.34%)
What were the highlights of his more recent work (between 2012-2020)?
- Immunology (53.63%)
- Cytotoxic T cell (61.45%)
- CD8 (41.34%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Immunology, Cytotoxic T cell, CD8, Antigen and Virus.
By researching both Immunology and C-C chemokine receptor type 7, he produces research that crosses academic boundaries.
His studies deal with areas such as Virology, T cell, Molecular biology and Effector, Cell biology as well as Cytotoxic T cell.
His CD28, CD3 and Granzyme study in the realm of CD8 interacts with subjects such as Population.
As a part of the same scientific family, Hanspeter Pircher mostly works in the field of Antigen, focusing on Immunotherapy and, on occasion, Dendritic cell, Cell growth and Antigen presentation.
His research in Virus intersects with topics in Cd4 t cell and B cell.
Between 2012 and 2020, his most popular works were:
- Inhibitory Receptor Expression Depends More Dominantly on Differentiation and Activation than "Exhaustion" of Human CD8 T Cells. (156 citations)
- Increased T-bet is associated with senescence of influenza virus-specific CD8 T cells in aged humans (50 citations)
- Inhibitory phenotype of HBV-specific CD4+ T-cells is characterized by high PD-1 expression but absent coregulation of multiple inhibitory molecules (40 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Gene
- Antibody
His primary areas of study are Cytotoxic T cell, Immunology, CD8, Antigen and T cell.
Hanspeter Pircher has researched Cytotoxic T cell in several fields, including Molecular biology, Cytokine and T-cell receptor.
His Molecular biology study integrates concerns from other disciplines, such as Cluster of differentiation, Lymphocytic choriomeningitis, Adoptive cell transfer, Lymphatic system and Antibody.
His Immunology study combines topics from a wide range of disciplines, such as Regulator, Transcription factor and Function.
His CD8 research is multidisciplinary, incorporating elements of Immunity and Effector.
His Interleukin 21 research incorporates themes from Natural killer T cell, Antigen-presenting cell and Virology.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
